Efficacy and safety of the novel α4</sub>β2</sub> neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
摘要：
α4</sub>β2</sub> Neuronal nicotinic receptors (NNRs) are implicated in the pathophysiology of attention-deficit/hyperactivity disorder (ADHD).
展开
年份：
2012
相似文献
参考文献
引证文献
来源期刊
站内活动
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
